Published in J Immunol on February 01, 1974
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest (1985) 3.40
Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. Nucleic Acids Res (1982) 2.01
Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun (1997) 1.60
Serum IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest (1975) 1.57
Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans. Infect Immun (1978) 1.13
Assessing mathematical models of influenza infections using features of the immune response. PLoS One (2013) 1.05
Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection. Infect Immun (2013) 0.87
Interferon deficiency syndrome. Clin Exp Immunol (1985) 0.85
In vitro suppression of fibroblast growth inhibitory lymphokine production by asbestos. Clin Exp Immunol (1983) 0.78
Generation and maintenance of immune interferon-producing cells induced by allogeneic stimulation in mice. Infect Immun (1980) 0.75
Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet (1975) 5.15
Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med (1977) 4.22
Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature (1986) 4.06
Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) (1971) 3.57
A unique set of polypeptides is induced by gamma interferon in addition to those induced in common with alpha and beta interferons. Nature (1983) 2.68
Pneumococcal polysaccharide immunization in infants and children. Pediatrics (1978) 2.67
B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA (1984) 2.63
Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50
Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem (1995) 2.38
Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet (1983) 2.30
Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med (1976) 1.91
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens. Cell Immunol (1974) 1.85
Immunologic responses in malnourished children. Am J Clin Nutr (1975) 1.78
PPD-stimulated interferon: in vitro macrophage-lymphocyte interaction in the production of a mediator of cellular immunity. Cell Immunol (1971) 1.75
Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination. Appl Microbiol (1972) 1.75
Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination. Proc Natl Acad Sci U S A (1972) 1.73
Thymosin activity in patients with cellular immunodeficiency. N Engl J Med (1975) 1.67
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
Maternal transmission of acquired immune deficiency syndrome. Pediatrics (1984) 1.60
Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet (1983) 1.55
Immunoglobulin G and M antibodies to pneumococcal polysaccharides detected by enzyme-linked immunosorbent assay. Infect Immun (1980) 1.46
Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc Natl Acad Sci U S A (1995) 1.45
An appraisal of an autoradiographic technique for enumeration of antibody containing cells in response to Salmonella somatic polysaccharide. Int Arch Allergy Appl Immunol (1967) 1.43
Immunoglobulin E deficiency in ataxia-telangiectasia. N Engl J Med (1969) 1.42
Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med (1997) 1.41
An intraosseous device for studies of bone-healing. The effect of transforming growth-factor beta. J Bone Joint Surg Am (1992) 1.38
The syndrome of cellular immunodeficiency with immunoglobulins. J Pediatr (1974) 1.36
Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report. Lancet (1980) 1.35
Unique antibody to basement membrane in patients with selective IgA deficiency and coeliac disease. Lancet (1971) 1.33
Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma. J Immunol (1988) 1.32
Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell Immunol (1980) 1.32
Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media. Infect Immun (1974) 1.30
Selective IgA deficiency and autoimmunity. Clin Exp Immunol (1970) 1.27
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay. Infect Immun (1981) 1.24
Immune globulin levels in colostrum and breast milk, and serum from formula- and breast-fed newborns. Proc Soc Exp Biol Med (1967) 1.23
Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta. Cell Immunol (1988) 1.23
Acquired immune deficiency syndrome in childhood. J Pediatr (1985) 1.22
The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction. J Immunol (1988) 1.20
Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic function. Am J Pediatr Hematol Oncol (1982) 1.20
Mitogen and antigen induction of interferon in vitro and in vivo. Tex Rep Biol Med (1977) 1.19
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol (1987) 1.17
IgG and IgM pneumococcal polysaccharide antibody responses in infants. Pediatr Res (1984) 1.16
Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin Immunol Immunopathol (1982) 1.14
Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16. Proc Natl Acad Sci U S A (1980) 1.13
Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. J Immunol (1991) 1.13
Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ (1998) 1.13
Virilizing ovarian tumor in a 2 1/2-year-old girl. J Pediatr (1967) 1.12
The DiGeorge syndrome and the fetal alcohol syndrome. Am J Dis Child (1982) 1.12
Localization fo the gene AVG for the antiviral expression of immune and classical interferon to the distal portion of the long arm of chromosome 21. J Infect Dis (1976) 1.11
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med (1984) 1.10
Protocols to establish genotype-phenotype correlations in Down syndrome. Am J Hum Genet (1991) 1.08
Maternal-fetal transfer of pneumococcal capsular polysaccharide antibodies. Am J Dis Child (1985) 1.08
Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor. J Immunol (1988) 1.08
The acquired immunodeficiency syndrome in infants and children. Ann Intern Med (1985) 1.08
Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): production of viable trisomy 16 diploid mouse chimeras. Dev Biol (1984) 1.07
Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells. J Clin Immunol (1985) 1.07
Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann Intern Med (1985) 1.07
Letter: T-cell rosettes in thyrotoxic Grave's disease. N Engl J Med (1973) 1.06
Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine. Rev Infect Dis (1981) 1.06
Growth retardation in sickle-cell disease treated by nutritional support. Lancet (1985) 1.06
Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanoma lysates. Proc Natl Acad Sci U S A (1993) 1.03
Multiple biotin-dependent carboxylase deficiencies associated with defects in T-cell and B-cell immunity. Lancet (1979) 1.03
Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21). J Immunol (1992) 1.02
Thymus transplantation. Permanent reconstitution of cellular immunity in a patient with sex-linked combined immunodeficiency. N Engl J Med (1973) 1.02
The antibody responses to pneumococcal capsular polysaccharides in aged individuals. Proc Soc Exp Biol Med (1980) 1.02
Mouse trisomy 16: an animal model of human trisomy 21 (Down syndrome). Ann N Y Acad Sci (1985) 1.02
Ichthyosis and neutral lipid storage disease. Am J Med Genet (1985) 1.02
Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-alpha receptor. Biochem Biophys Res Commun (1982) 1.02
T-lymphocyte subsets in lymph nodes from homosexual men. JAMA (1983) 1.01
Structure-activity studies of interleukin-2. Science (1986) 1.00
Elevated IGA in carcinoma of the nasopharynx. Cancer (1975) 1.00
Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique. Ann N Y Acad Sci (1980) 1.00
A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer (1971) 0.99
Altered distribution of B and T lymphocytes in lymph-nodes from homosexual men with Kaposi's sarcoma. Lancet (1983) 0.98
Immobilized pH gradient two-dimensional gel electrophoresis and mass spectrometric identification of cytokine-regulated proteins in ME-180 cervical carcinoma cells. Electrophoresis (1997) 0.98
Significance of a positive antinuclear antibody test in a pediatric population. Am J Dis Child (1983) 0.97
Selective absence of IgA. Autoimmune phenomena and autoimmune disease. Am J Pathol (1972) 0.97
Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect ot interferon. Cell Immunol (1980) 0.96
Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). J Immunol (1986) 0.96
Spectrum of Sjögren syndrome in children. J Pediatr (1981) 0.96
In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease. Ann N Y Acad Sci (1979) 0.96
Impaired mononuclear-cell proliferation in patients with the acquired immune deficiency syndrome results from abnormalities of both T lymphocytes and adherent mononuclear cells. J Clin Immunol (1985) 0.95
The in vivo induction of mouse lymphocyte transformation by phytohemagglutinin. J Immunol (1968) 0.95
Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Pediatr Res (1988) 0.94
Editorial: Thymic cells and humoral factors as therapeutic agents. Pediatrics (1976) 0.94
Interferon-gamma and synthesis of surfactant components by cultured human fetal lung. Am J Respir Cell Mol Biol (1990) 0.94
The chromosomal location of mouse interferon alpha genes. EMBO J (1984) 0.93
Human T-lymphocyte subset production of immune (gamma) interferon. J Clin Immunol (1981) 0.93
Antibody-mediated immunodeficiency in short-limbed dwarfism. J Pediatr (1974) 0.93
Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol (1981) 0.93
Interferon-gamma: success, structure and speculation. Nature (1982) 0.92
T-lymphocyte function and sensitivity to interferon in trisomy 21. Cell Immunol (1980) 0.92
Antibody-dependent lymphocyte killer function in human immunodeficiency diseases. Clin Exp Immunol (1975) 0.92
Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha. Transplantation (1989) 0.92
Functional implications of gene dosage effects in trisomy 21. Hum Genet Suppl (1981) 0.92